In the context of the current discussion on possible tax reforms in Argentina, Julián Folgar analyzes one of the most relevant and yet least understood taxes in the system: the VAT (Value Added Tax) ...

At a time when companies are managing more expensive clinical trials with less funding, any opportunity to reduce trial costs is vital to keep small and medium biotechs on their feet. For companies ...